GRIDS Capital

GRIDS Capital, founded in 2016 and based in São Paulo, Brazil, is a venture capital firm specializing in deep technology investments. The firm focuses on sectors such as artificial intelligence, robotics, life sciences, nanotechnology, and advanced materials, among others. GRIDS Capital aims to support companies that are at the intersection of science and technology, fostering innovation through the development of new algorithms, systems, and devices. By collaborating with entrepreneurs, researchers, and experts across various fields, GRIDS Capital seeks to contribute to the advancement of solutions that promise to enhance future living standards.

Guy Perelmuter

Co-Founder and CEO

Isabelle Perelmuter

Co-Founder and General Partner

49 past transactions

Foundation EGI

Seed Round in 2025
Foundation EGI is a technology company that develops artificial intelligence and large language model (LLM) tools for enterprises in design and manufacturing. Its platform aims to streamline and accelerate all stages of the product development cycle, from design and research to production and documentation. By leveraging LLM, advanced AI, and computer graphics, the company helps engineers enhance product quality, boost productivity, and reduce costs throughout the design and manufacturing process.

Atrandi Biosciences

Series A in 2025
Atrandi Biosciences is a privately held biotechnology company that focuses on next-generation single-cell technology, specifically single-cell eukaryotic DNA sequencing. By leveraging proprietary microfluidics technology, Atrandi develops hardware systems, consumables, and software services designed to create user-friendly workflows. This innovative approach facilitates the analysis of genomic alterations and cellular heterogeneity, enabling researchers to effectively study complex biological systems at the single-cell and single-molecule levels.

Passkey

Seed Round in 2024
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Plotlogic

Series B in 2023
Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Hedera Dx

Seed Round in 2022
Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

BigHat Biosciences

Series B in 2022
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.

FORT Robotics

Series B in 2022
FORT Robotics, Inc. is a company based in Philadelphia, Pennsylvania, that specializes in the development and manufacturing of wireless control systems designed for dangerous machines. The company provides a range of products, including industrial wireless remote control systems, safety devices, and wireless emergency stop systems, which enhance productivity while preventing accidents. FORT Robotics' solutions are utilized in various sectors, such as construction, agriculture, manufacturing, warehousing, transportation, and mobile robotics. By focusing on safety technology, FORT aims to build a comprehensive safety and security platform for smart machines, facilitating the safe integration of automation in industrial applications. The company leverages over a decade of experience to help users and builders of robotic systems accelerate development, mitigate risks, and ensure reliable operation around autonomous systems.

CloudNC

Series B in 2022
CloudNC Ltd. is a London-based company that develops advanced software to automate the programming of numerically controlled (NC) machine tools, particularly focusing on computerized numerical control (CNC) milling machines. Founded in 2015, the company aims to transform the manufacturing industry by enabling factories to autonomously produce precision parts, which are essential for various sectors, including automotive, aerospace, and technology. By streamlining the production process, CloudNC's technology reduces the need for skilled human intervention, allowing for more efficient and sustainable manufacturing practices. The company seeks to enhance productivity and scalability, ultimately making manufacturing ten times more efficient than current standards. Through its innovative approach, CloudNC is positioned to revitalize the manufacturing landscape and contribute to a cleaner, more sustainable industrial revolution.

ALICE Technologies

Series B in 2022
ALICE Technologies is a developer of an AI-powered construction simulation platform designed to optimize building processes. The platform utilizes advanced artificial intelligence to analyze complex project requirements, generating efficient schedules and resource allocations. This capability allows construction professionals to estimate costs and timelines accurately while adapting to changes throughout the construction cycle. By streamlining planning and execution, ALICE Technologies helps contractors and project owners reduce construction times and labor costs significantly, with typical savings of $30 million on projects valued at $500 million. The company collaborates with leading firms in the infrastructure and commercial construction sectors, enhancing their ability to manage projects effectively.

Dusty Robotics

Series B in 2022
Dusty Robotics, Inc. is a technology company that specializes in automated layout services for the construction industry. Founded in 2018 and headquartered in Mountain View, California, the company has developed the FieldPrinter, a robotic tool that translates digital building information modeling (BIM) designs into accurate, on-site layouts. By integrating BIM information directly onto construction-site floors, Dusty Robotics eliminates manual processes, thereby enhancing efficiency in the construction workflow. The company's innovative solutions serve a diverse clientele, including owners, general contractors, subcontractors, and builders, helping them to reduce labor and material waste and improve the overall design-build-operate lifecycle.

Hedera Dx

Seed Round in 2022
Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

Plotlogic

Series A in 2022
Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

CloudNC

Series A in 2022
CloudNC Ltd. is a London-based company that develops advanced software to automate the programming of numerically controlled (NC) machine tools, particularly focusing on computerized numerical control (CNC) milling machines. Founded in 2015, the company aims to transform the manufacturing industry by enabling factories to autonomously produce precision parts, which are essential for various sectors, including automotive, aerospace, and technology. By streamlining the production process, CloudNC's technology reduces the need for skilled human intervention, allowing for more efficient and sustainable manufacturing practices. The company seeks to enhance productivity and scalability, ultimately making manufacturing ten times more efficient than current standards. Through its innovative approach, CloudNC is positioned to revitalize the manufacturing landscape and contribute to a cleaner, more sustainable industrial revolution.

MontyCloud

Seed Round in 2022
MontyCloud Inc. is a technology company founded in 2018 and based in Woodinville, Washington, that specializes in developing an artificial intelligence-driven SaaS platform for the management and governance of cloud infrastructure, applications, and services. The platform employs an event-driven architecture that leverages AI and machine learning to automate maintenance tasks, monitor cloud services, and provide actionable insights. MontyCloud's solutions encompass various aspects of cloud management, including cost management, security, compliance automation, and disaster recovery, allowing clients to achieve policy-driven, application-centric management across diverse cloud environments.

Ingenuity Foods

Series A in 2022
Ingenuity Foods, Inc.

Endpoint Health

Series A in 2022
Endpoint Health, Inc. is a precision immunology company focused on researching and developing therapies that enhance outcomes for patients with critical and immune-driven illnesses, including sepsis, acute respiratory distress syndrome, and COVID-19. Founded in 2018 and headquartered in Palo Alto, California, with additional offices in Detroit, Livonia, and Chicago, the company aims to overcome the limitations of traditional drug development by creating precision therapies tailored to individual patient needs. Utilizing its proprietary AI-powered platform, OMNAI, Endpoint Health identifies and matches high-potential therapies to patients most likely to benefit, ensuring personalized treatment that significantly improves health outcomes. The company is committed to delivering innovative solutions that address the complexities of autoimmune and inflammatory conditions.

Halter

Series B in 2021
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in developing GPS-enabled, solar-powered tracking devices for livestock. The company manufactures innovative collars designed for cows, allowing farmers to monitor and guide their animals across pastures. Halter's technology enables virtual fencing, helping farmers optimize productivity while promoting sustainable farming practices. By enhancing the management of livestock, Halter aims to improve agricultural efficiency and animal welfare, contributing to the overall sustainability of pasture-based farming.

Mesodyne

Seed Round in 2021
Mesodyne is an engineering and manufacturing company focused on innovative electricity generation solutions, notably through its patented LightCell technology, which efficiently converts various fuels into electricity using light. Founded in 2018 by Drs. Veronika Stelmakh and Walker Chan, the company aims to deliver robust, portable, and reliable power generation systems tailored for military and commercial applications. Mesodyne's compact power generators enhance the endurance of small autonomous systems by providing efficient alternatives to traditional batteries, thereby reducing the burden on dismounted warfighters and emergency responders. Additionally, these generators extend the operational range of unmanned vehicles, wearables, and other critical equipment, bridging the gap between batteries and internal combustion engines.

Loft Orbital

Series B in 2021
Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

Culture Biosciences

Series B in 2021
Culture Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that offers an innovative biomanufacturing platform designed for scientists to efficiently run, monitor, and analyze bioreactor experiments through the cloud. Founded in 2016, the company specializes in developing automated bioreactors and fermentation tools that enable biotech companies to optimize their manufacturing processes. By leveraging robotic sample handling and cloud-based data monitoring and analysis, Culture Biosciences significantly accelerates the ability of scientists to manage bioreactor operations compared to traditional methods. This allows for faster product development and market readiness, streamlining the biomanufacturing workflow for its clients.

Syntegra

Seed Round in 2021
Syntegra is a company specializing in the generation of synthetic healthcare data that preserves privacy while maintaining the statistical properties of the original data. By employing advanced machine learning techniques, Syntegra creates validated synthetic data derivatives that do not contain any identifiable information, thus addressing the increasing barriers to clinical data access faced by healthcare systems and data aggregators. The company provides an open-access data platform that allows users to conduct analytics, build predictive models, and generate synthetic control groups for clinical trials. Its approach ensures compliance with privacy regulations such as HIPAA and GDPR, with multiple validation methods in place to safeguard data integrity. Syntegra's scalable solution is adaptable to various data types, including images and sensor streams, and is designed to enhance patient care and clinical outcomes. The company is led by a team of experienced entrepreneurs and academics with expertise in medicine and data science.

Fauna Bio

Seed Round in 2021
Fauna Bio Incorporated is a biotechnology company based in San Francisco, California, that focuses on developing a cross-mammal drug discovery platform aimed at treating human diseases. Established in 2018 by a team of scientists with expertise in non-model organisms, the company investigates the biological mechanisms found in hibernating and deep-diving animals to uncover potential therapeutic applications for conditions such as heart disease and neurodegenerative disorders. By leveraging data from a diverse range of species, Fauna Bio aims to identify novel drug targets and facilitate pre-clinical and early clinical testing for new therapeutics, ultimately helping humans recover from serious medical emergencies like trauma, heart attacks, and strokes.

Heliogen

Series B in 2020
Heliogen, Inc. is a clean energy company based in Pasadena, California, that specializes in renewable energy technology aimed at replacing fossil fuels in heavy industries. Founded in 2013, Heliogen has developed an AI-enabled, modular concentrated solar system that efficiently harnesses sunlight to produce hydrogen and syngas fuels. Its offerings include HelioMax, a closed-loop control system for electricity generation and process heat; HelioHeat, which provides carbon-free high-temperature heat for sectors such as cement, refining, and mining; and HelioFuel, renewable fuels suitable for transportation, heavy equipment, and residential heating. Heliogen's innovative approach aspires to deliver cost-effective, near 24/7 carbon-free energy at scale, marking a significant advancement in sustainable energy solutions.

Stable

Seed Round in 2020
Stable provides software solutions designed to assist electric vehicle (EV) fleets and charging providers in efficiently planning and managing their charging infrastructure. Founded in 2016 and based in San Francisco, the company offers a siting and forecasting platform that utilizes a proprietary machine learning model to predict site utilization and optimize the placement and sizing of charging stations. By consolidating essential data and insights, Stable enables customers to make informed decisions regarding the deployment of charging stations, ensuring that they are installed in locations where they are most needed.

Flex Logix

Convertible Note in 2020
Flex Logix is a semiconductor and software company founded in 2014 and based in Mountain View, California. The company specializes in embedding field-programmable gate arrays (FPGAs) of any size within integrated circuits. Its innovative technology allows chips to change their functionality even after shipment, enabling chip designers to reconfigure essential register-transfer levels both within the integrated circuit and across the entire system. Flex Logix generates revenue through a licensing model that includes the delivery of design files and tools, an annual license for its EFLX Compiler for ongoing programming needs, and royalties based on usage.

Senti Bio

Series A in 2020
Senti Bio, established in 2016 and headquartered in South San Francisco, specializes in synthetic biotechnology for therapeutic development. The company's core focus is engineering gene circuits, a platform technology that enables precise control over cellular behavior. Senti Bio's innovative approach allows for the creation of therapies with enhanced specificity and control, particularly in oncology. Their product pipeline includes SENTI-202, a targeted cancer therapy using gene-engineered allogeneic CAR-NK cells designed to eliminate cancer cells while sparing healthy bone marrow, and SENTI-301A for treating hepatocellular carcinoma.

Momentus

Series B in 2020
Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft, focusing on in-space infrastructure. Momentus offers a range of services, including space transportation, hosted payloads, and in-orbit servicing, utilizing innovative water plasma-based propulsion technology that is currently under development. Its transfer and service vehicles are designed to carry satellites and hosted payloads between different orbits, supporting the growing demands of the new space economy.

nTopology

Series C in 2020
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Dishcraft Robotics

Series A in 2020
Dishcraft Robotics, Inc. specializes in developing and manufacturing robotic systems for commercial kitchens, aiming to enhance productivity and reduce waste in the food service industry. The company's innovative technology includes a dishwashing solution that utilizes a rotating scrubber head and advanced computer vision to clean and inspect each dish individually, ensuring thorough sanitation in a fraction of a second. Dishcraft's service, known as Dishcraft Daily, offers comprehensive dishwashing solutions tailored for corporate kitchens and restaurants. Founded in 2015 and based in San Carlos, California, Dishcraft Robotics was previously known as Bistro Technologies, Inc. and rebranded in March 2016.

Matterport

Series D in 2020
Matterport is a spatial data company specializing in the digitization and indexing of the built environment. Its comprehensive 3D data platform enables users to create accurate and immersive digital twins of physical spaces. These digital representations can be utilized for various purposes, including design, development, operation, promotion, and analysis of environments. The company generates revenue primarily through subscription fees from customers who access its platform, along with income from licenses, services, and product sales. Matterport's innovative approach facilitates a deeper understanding of spaces, making it a valuable tool for industries such as real estate, architecture, and construction.

ThruWave

Seed Round in 2020
ThruWave is a technology company that specializes in millimeter wave imaging solutions for various commercial and industrial applications. Founded in 2017 and based in Seattle, Washington, ThruWave offers low-cost sensors that leverage patent-pending radar signal processing and GPU-accelerated image reconstruction techniques. Its innovative technology is designed for multiple markets, including robotics, construction, and quality control. By enabling the imaging of internal structures such as walls, ceilings, and floors, ThruWave's solutions enhance operational efficiency and reduce risks for construction professionals. Additionally, its systems assist in inventory verification, shipment validation, and detecting packaging issues, thereby empowering clients to automatically verify proper packaging, count contents, and identify damaged or missing items.

Avail Medsystems

Series A in 2020
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

FIGUR8

Seed Round in 2020
FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software solutions that enhance the efficiency of assembly lines, enabling them to operate autonomously while adapting to various parts and processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to reduce costs associated with scrap and rework by allowing manufacturers to identify and resolve issues on their assembly lines. Instrumental's technology has been deployed in multiple global assembly lines at leading manufacturers, helping to prevent delays in development schedules and start production at higher yields. In addition to its software offerings, Instrumental also provides services related to high-performance computing, data storage, and business continuity, catering to both commercial and government sectors. The firm is headquartered in Saint Paul, Minnesota, and has been operational since 1991.

OPT Industries

Pre Seed Round in 2019
OPT Industries, founded by Jifei Ou in Cambridge, Massachusetts in 2019, specializes in digital manufacturing at the micron-scale. The company employs vertically integrated machinery, software, and design expertise to deliver precision-engineered products at high volumes with shortened lead times. Its technology enables globally-recognized brands to develop novel product concepts and bring them swiftly to commercialization.

CytoVale

Series B in 2019
CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.

Plotlogic

Seed Round in 2019
Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Flex Logix

Series C in 2019
Flex Logix is a semiconductor and software company founded in 2014 and based in Mountain View, California. The company specializes in embedding field-programmable gate arrays (FPGAs) of any size within integrated circuits. Its innovative technology allows chips to change their functionality even after shipment, enabling chip designers to reconfigure essential register-transfer levels both within the integrated circuit and across the entire system. Flex Logix generates revenue through a licensing model that includes the delivery of design files and tools, an annual license for its EFLX Compiler for ongoing programming needs, and royalties based on usage.

Momentus

Series A in 2019
Momentus Inc. is a commercial space company based in Santa Clara, California, founded in 2017. The company specializes in providing water-powered transportation services for spacecraft, focusing on in-space infrastructure. Momentus offers a range of services, including space transportation, hosted payloads, and in-orbit servicing, utilizing innovative water plasma-based propulsion technology that is currently under development. Its transfer and service vehicles are designed to carry satellites and hosted payloads between different orbits, supporting the growing demands of the new space economy.

Particle

Series C in 2019
Particle Industries, Inc. is a provider of a comprehensive platform designed for the prototyping, scaling, and management of Internet of Things (IoT) products. The company offers a range of hardware development kits, including the Photon for Wi-Fi projects and the Electron for cellular-connected devices, along with various accessories like antennas and USB shields. Particle also delivers software tools such as Tinker, a mobile application for remote control, and Particle Build, a web-based development environment that allows users to write and deploy code easily. Its cloud platform facilitates secure interactions with connected devices through modern APIs, supporting developers in creating intelligent web services. With over 150,000 product builders across more than 170 countries, including notable clients like NASA and SpaceX, Particle has established itself as a key player in the IoT landscape. Founded in 2012 and headquartered in San Francisco, California, with an additional office in Shenzhen, China, the company has been recognized for its innovation and impact in the IoT sector.

Avail Medsystems

Convertible Note in 2019
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Optimus Ride

Series B in 2019
Optimus Ride is a self-driving vehicle company located in Boston, Massachusetts, focused on developing technologies that promote efficient, sustainable, and equitable mobility systems. As a spinoff from the Massachusetts Institute of Technology, the company leverages over 30 years of interdisciplinary research in self-driving technologies, electric vehicles, and Mobility-on-Demand Systems. Optimus Ride specializes in creating self-driving technology systems tailored for geofenced environments, utilizing innovations in complex sensor fusion, mapping, computer vision, and machine learning. The company's expertise is further enhanced by a team with extensive industrial and entrepreneurial experience in manufacturing robots, urban design, and shared vehicle fleet management, allowing it to offer versatile transportation solutions that range from commercial vessel operations to transit options.

FIGUR8

Convertible Note in 2019
FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Fauna Bio

Seed Round in 2019
Fauna Bio Incorporated is a biotechnology company based in San Francisco, California, that focuses on developing a cross-mammal drug discovery platform aimed at treating human diseases. Established in 2018 by a team of scientists with expertise in non-model organisms, the company investigates the biological mechanisms found in hibernating and deep-diving animals to uncover potential therapeutic applications for conditions such as heart disease and neurodegenerative disorders. By leveraging data from a diverse range of species, Fauna Bio aims to identify novel drug targets and facilitate pre-clinical and early clinical testing for new therapeutics, ultimately helping humans recover from serious medical emergencies like trauma, heart attacks, and strokes.

nTopology

Series B in 2019
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Nautilus Labs

Series A in 2019
Nautilus Labs Inc. is a technology company that specializes in developing analytical solutions for maritime transportation. Founded in 2016 and based in New York, it offers a platform that unifies and analyzes vessel data in real time, enabling operators to make informed business decisions. The platform includes features such as TrueVoyage, which provides continuous monitoring of ship performance and critical reporting values. Nautilus Labs aims to enhance fleet efficiency by applying machine learning to optimize operational performance while reducing fuel consumption. Its solutions are designed to integrate seamlessly with clients' existing workflows and are supported by change management programs to facilitate organizational adoption. The company serves various sectors within the maritime industry, including gas carriers, tankers, container ships, bulk carriers, and roll-on/roll-off vessels.

Recursion Pharmaceuticals

Series C in 2019
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.

Immusoft

Series B in 2019
Immusoft Corporation is a biotechnology company focused on developing an autologous cell therapy platform aimed at treating a range of human diseases through its proprietary Immune System Programming (ISP) technology. Founded in 2009 and based in Seattle, Washington, Immusoft specializes in modifying the DNA of a patient's immune cells to create biofactories capable of producing gene-encoded medicines, including essential proteins and enzymes that may be missing or defective. The company's innovative approach involves reprogramming B cells, a type of immune cell, which enables them to manufacture and secrete various antibodies. This process not only provides a potential long-term solution for patients but also positions Immusoft at the forefront of biotechnology in addressing rare and infectious diseases.

CytoVale

Series B in 2018
CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.